Lipid Nanoparticles
Nanoscale lipid carriers used to protect and deliver fragile therapeutic molecules such as RNA into cells.
Core metadata
- ID: lipid_nanoparticles
- Era: Modern
- First known date: 1995 (decade)
- Region: Global drug-delivery research
- Review status: source_checked
- Maturity: established
Prerequisites
Dependents
- CRISPR Delivery: AAV, LNP, and RNP (crispr_delivery_aav_lnp_rnp)
- Messenger RNA Therapeutics (messenger_rna_therapeutics)
- mRNA Vaccines (mrna_vaccines)
- Nanomedicine Drug Delivery (nanomedicine_drug_delivery)
- Tissue-Targeted Editor Delivery (tissue_targeted_editor_delivery)
Fields
Field lanes
- Pharmaceuticals & Drug Development: Drug Delivery & Formulation
Node sources
- Morphological Characterization of Self-Amplifying mRNA Lipid Nanoparticles (NIST, 2024, official_agency) • Supports: node, maturity
- Lipid nanoparticles for mRNA delivery (PubMed, 2021, review) • Supports: node, maturity
Prerequisite edge evidence
Edge/source evidence summary:
- Prerequisite edges: 2
- Average edge confidence: 72%
- Prerequisite sources: 2
- expert_inference: 2
| Prerequisite | Type | Confidence | Evidence level | Note | Sources |
|---|---|---|---|---|---|
| Nanotechnology (Early Research) (nanotechnology_early) | historical_predecessor | 75% | expert_inference | Nanotechnology (Early Research) is an earlier historical predecessor or foundation, not a one-to-one engineering dependency. |
|
| Biochemistry (biochemistry) | enabling | 68% | expert_inference | Biochemistry provides a capability that enables this technology without being the only possible path. |
|
This page is generated from canonical era JSON and is indexable by URL.